Your browser doesn't support javascript.
loading
Serum soluble BCMA can be used to monitor relapse of multiple myeloma patients after chimeric antigen receptor T-cell immunotherapy.
Shen, Ying; Liu, Jie; Wang, Baiyan; Zhang, Yilin; Xu, Yan; Wang, Xiaman; Jia, Yachun; Meng, Xin; Wang, Xugeng; Fan, Xiaohu; He, Aili; Zhao, Wanhong.
Afiliación
  • Shen Y; Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Liu J; Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Wang B; Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Zhang Y; Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Xu Y; Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Wang X; Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Jia Y; Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Meng X; Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Wang X; Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Fan X; Nanjing Legend Biotech Inc., Nanjing, China.
  • He A; Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China; National-Local Joint Engineering Research Center of Biodiagnostics & Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Zhao W; Department of Hematology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. Electronic address: zhaowanhong68@163.com.
Curr Res Transl Med ; 71(2): 103378, 2023.
Article en En | MEDLINE | ID: mdl-36720180
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Receptores Quiméricos de Antígenos / Mieloma Múltiple Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Curr Res Transl Med Año: 2023 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Receptores Quiméricos de Antígenos / Mieloma Múltiple Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Curr Res Transl Med Año: 2023 Tipo del documento: Article País de afiliación: China